SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)

García‑Sáenz, José Ángel; Blancas López-Barajas, María Isabel

doi:10.1007/s12094-023-03203-8

s12094-023-03203-8.pdf (1.415Mo)

CORRECTIONs12094-023-03229-y.pdf (404.4Ko)

Identificadores

URI: https://hdl.handle.net/10481/83639

DOI: 10.1007/s12094-023-03203-8

Exportar

Editorial

Springer

Materia

Advanced breast cancer

ABC

Guidelines

Endocrine therapy

Anti-HER2 therapy

IOT

ADC

Date

2023-05-06

Referencia bibliográfica

Garcia-Saenz, J.A., Blancas, I., Echavarria, I. et al. SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022). Clin Transl Oncol (2023). [https://doi.org/10.1007/s12094-023-03203-8]

Résumé

Advanced breast cancer represents a challenge for patients and for physicians due its dynamic genomic changes yielding to a resistance to treatments. The main goal is to improve quality of live and survival of the patients through the most appropriate subsequent therapies based on the knowledge of the natural history of the disease. In these guidelines, we summarize current evidence and available therapies for the medical management of advanced breast cancer.

Colecciones

DMed - Artículos

Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional